Signaling molecules in overcirculation-induced pulmonary hypertension in piglets - Effects of sildenafil therapy

被引:62
作者
Rondelet, B
Kerbaul, F
Van Beneden, R
Motte, S
Fesler, P
Hubloue, I
Remmelink, M
Brimioulle, S
Salmon, I
Ketelslegers, JM
Naeije, R
机构
[1] Free Univ Brussels, Fac Med, Physiol Lab, B-1070 Brussels, Belgium
[2] Catholic Univ Louvain, Unit Diabet & Nutr, Brussels, Belgium
[3] Free Univ Brussels, Erasme Hosp, Dept Pathol, B-1050 Brussels, Belgium
关键词
angiopoietins; heart defects; nitric oxide; remodeling; hypertension; pulmonary;
D O I
10.1161/01.CIR.0000143836.40431.F5
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background-The phosphodiesterase type-5 (PDE-5) inhibitor sildenafil has been reported to improve pulmonary arterial hypertension (PAH), but the mechanisms that account for this effect are incompletely understood. Severe pulmonary hypertension has been characterized by defects in a signaling pathway involving angiopoietin-1 and the bone morphogenetic receptor-2 (BMPR-2). We investigated the effects of sildenafil on hemodynamics and signaling molecules in a piglet overcirculation-induced model of early PAH. Methods and Results-Thirty 3-week-old piglets were randomized to placebo or sildenafil therapy 0.75 mg/kg TID after anastomosis of the left subclavian artery to the pulmonary arterial trunk or after a sham operation. Three months later, the animals underwent a hemodynamic evaluation followed by pulmonary tissue sampling for morphometry, immunohistochemistry or radioimmunoassay, and real-time quantitative-polymerase chain reaction. Chronic systemic-to-pulmonary shunting increased pulmonary mRNA for angiopoietin-1, endothelin-1 (ET-1), angiotensin II, inducible nitric oxide synthase, vascular endothelial growth factor, and PDE-5. Pulmonary messenger RNA for BMPR-1A and BMPR-2 decreased. Pulmonary angiotensin II, ET-1, and vascular endothelial growth factor proteins increased. Pulmonary artery pressure increased from 20+/-2 to 33+/-1 mm Hg, and arteriolar medial thickness increased by 91%. The expressions of angiopoietin-1, ET-1, and angiotensin II were tightly correlated to pulmonary hypertension. Sildenafil prevented the increase in pulmonary artery pressure, limited the increase in medial thickness to 41%, and corrected associated biological perturbations except for the angiopoietin-1/BMPR-2 pathway, PDE-5, and angiotensin II. Conclusions-Sildenafil partially prevents overcirculation-induced PAH and associated changes in signaling molecules. Angiotensin II, PDE-5, and angiopoietin-1/BMPR-2 signaling may play a dominant role in the early stages of the disease.
引用
收藏
页码:2220 / 2225
页数:6
相关论文
共 29 条
[1]   Vascular remodeling and ET-1 expression in rat strains with different responses to chronic hypoxia [J].
Aguirre, JI ;
Morrell, NW ;
Long, L ;
Clift, P ;
Upton, PD ;
Polak, JM ;
Wilkins, MR .
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, 2000, 278 (05) :L981-L987
[2]   Primary pulmonary hypertension - A vascular biology and translational research "work in progress" [J].
Archer, S ;
Rich, S .
CIRCULATION, 2000, 102 (22) :2781-2791
[3]   Canine ventricular myocytes possess a renin-angiotensin system that is upregulated with heart failure [J].
Barlucchi, L ;
Leri, A ;
Dostal, DE ;
Fiordaliso, F ;
Tada, H ;
Hintze, TH ;
Kajstura, J ;
Nadal-Ginard, B ;
Anversa, P .
CIRCULATION RESEARCH, 2001, 88 (03) :298-304
[4]   sGC and PDE5 are elevated in lambs with increased pulmonary blood flow and pulmonary hypertension [J].
Black, SM ;
Sanchez, LS ;
Mata-Greenwood, E ;
Bekker, JM ;
Steinhorn, RH ;
Fineman, JR .
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, 2001, 281 (05) :L1051-L1057
[5]   Familial primary pulmonary hypertension (gene PPH1) is caused by mutations in the bone morphogenetic protein receptor-II gene [J].
Deng, ZM ;
Morse, JH ;
Slager, SL ;
Cuervo, N ;
Moore, KJ ;
Venetos, G ;
Kalachikov, S ;
Cayanis, E ;
Fischer, SG ;
Barst, RJ ;
Hodge, SE ;
Knowles, JA .
AMERICAN JOURNAL OF HUMAN GENETICS, 2000, 67 (03) :737-744
[6]   EFFECTS OF ENDOTHELIN-1 AT PATHOPHYSIOLOGIC CONCENTRATIONS ON CORONARY PERFUSION AND MECHANICAL FUNCTION OF NORMAL AND POSTISCHEMIC MYOCARDIUM [J].
DONCKIER, J ;
HANET, C ;
STOLERU, L ;
VANMECHELEN, H ;
GALANTI, L ;
HAYASHIDA, W ;
KEYEUX, A ;
KETELSLEGERS, JM ;
POULEUR, H .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1994, 23 (02) :212-219
[7]  
Du Lingling, 2003, New England Journal of Medicine, V348, P500, DOI 10.1056/NEJMoa021650
[8]   Pathobiology of pulmonary arterial hypertension [J].
Eddahibi, S ;
Morrell, N ;
D'Ortho, MP ;
Naeije, R ;
Adnot, S .
EUROPEAN RESPIRATORY JOURNAL, 2002, 20 (06) :1559-1572
[9]   Clinical classification of pulmonary hypertension [J].
Fishman, AP .
CLINICS IN CHEST MEDICINE, 2001, 22 (03) :385-+
[10]   RETRACTED: Angiotensin AT1 and AT2 receptors differentially regulate angiopoietin-2 and vascular endothelial growth factor expression and angiogenesis by modulating heparin binding-epidermal growth factor (EGF)-mediated EGF receptor transactivation (Retracted Article) [J].
Fujiyama, S ;
Matsubara, H ;
Nozawa, Y ;
Maruyama, K ;
Mori, Y ;
Tsutsumi, Y ;
Masaki, H ;
Uchiyama, Y ;
Koyama, Y ;
Nose, A ;
Iba, O ;
Tateishi, E ;
Ogata, N ;
Jyo, N ;
Higashiyama, S ;
Iwasaka, T .
CIRCULATION RESEARCH, 2001, 88 (01) :22-29